Company Update (NASDAQ:ILMN): Illumina, Inc. to Announce First Quarter 2015 Financial Results on Tuesday, April 21, 2015

Illumina, Inc. (NASDAQ:ILMN) announced that it will issue results for first quarter 2015 following the close of market on Tuesday, April 21, 2015.

On the same day, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern TimeJay Flatley, Chief Executive Officer, Francis deSouza, President, and Marc Stapley, Senior Vice President and Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Tuesday, April 21, 2015. Interested parties may listen to the call by dialing 888.679.8034 (passcode: 50211546), or if outside North America by dialing +1.617.213.4847 (passcode: 50211546). Individuals may access the live teleconference in the Investor Relations section of Illumina’s web site under the “Company” tab at

A replay of the conference call will be available from 6:00 p.m. Pacific Time (9:00 p.m. Eastern Time) on April 21, 2015 through April 28, 2015 by dialing 888.286.8010 (passcode: 41280552), or if outside North America by dialing +1.617.801.6888 (passcode: 41280552). (Original Source)

Shares of Illumina closed yesterday at $182.79 . ILMN has a 1-year high of $213.33 and a 1-year low of $127.69. The stock's 50-day moving average is $193.05 and it's 200-day moving average is $185.96.

On the ratings front, Illumina has been the subject of a number of recent research reports. In a report issued on March 31, BTIG analyst Dane Leone maintained a Buy rating on ILMN, with a price target of $240, which represents a potential upside of 31.3% from where the stock is currently trading. Separately, on February 2, Cantor Fitzgerald's Sung Ji Nam maintained a Hold rating on the stock and has a price target of $166.

According to, which ranks over 7,500 financial analysts and bloggers to gauge the performance of their past recommendations, Dane Leone and Sung Ji Nam have a total average return of 11.1% and 13.5% respectively. Leone has a success rate of 69.6% and is ranked #990 out of 3568 analysts, while Nam has a success rate of 94.1% and is ranked #470.

In total, one research analyst has assigned a Hold rating and 5 research analysts have given a Buy rating to the stock. When considering if perhaps the stock is under or overvalued, the average price target is $182.79 which is 22.7% above where the stock closed yesterday.

Illumina Inc providessequencing-and array-based solutions for genetic analysis. Its products enabled researchers to explore DNA, helping them create the first map of gene variations associated with health, disease, and drug response.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts